comparemela.com
Home
Live Updates
AR Inhibitors in nmCRPC: Real-World Data : comparemela.com
AR Inhibitors in nmCRPC: Real-World Data
Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.
Related Keywords
,
Key Updates
,
Metastatic Prostate Cancer Treatment
,
Real World Data
,
Prostate Cancer
,
Nonmetastatic Castration Resistant Prostate Cancer
,
Nmcrpc
,
Crpc
,
Ar Inhibitors
,
Androgen Receptor Inhibitors
,
Apalutamide
,
Enzalutamide
,
Darolutamide
,
Dear Study
,
Dear Trial
,
Spartan Trial
,
Spartan Study
,
Prosper Trial
,
Prosper Study
,
Aramis Trial
,
Aramis Study
,
comparemela.com © 2020. All Rights Reserved.